# An Acute Migraine Factorial Study

> **NCT06245902** · PHASE2 · COMPLETED · sponsor: **Allodynic Therapeutics, Inc** · enrollment: 92 (actual)

## Conditions studied

- Migraine With or Without Aura

## Interventions

- **DRUG:** Naltrexone and Acetaminophen
- **DRUG:** Naltrexone and Acetaminophen-High Dose
- **DRUG:** Naltrexone Alone (regular dose)
- **DRUG:** Acetaminophen Alone
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT06245902
- **Lead sponsor:** Allodynic Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-18
- **Primary completion:** 2018-02-08
- **Final completion:** 2018-02-08
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06245902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06245902, "An Acute Migraine Factorial Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06245902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*